State Street Amends Novavax Stake, Signals Institutional Confidence
Ticker: NVAX · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street just updated its Novavax holdings, showing continued institutional interest.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 25, 2024, disclosing its ownership of Novavax Inc. common stock as of December 31, 2023. This filing indicates that State Street Corporation holds a significant, though not specified, stake in Novavax, a biotechnology company. This matters to investors because large institutional holdings like State Street's can signal confidence in the company's future, potentially influencing stock stability and investor sentiment.
Why It Matters
Large institutional ownership by entities like State Street can provide a layer of stability to a stock and may be seen as a vote of confidence by other investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not indicate any immediate negative or positive financial risk.
Analyst Insight
Investors should note State Street's continued institutional presence in Novavax, but this filing alone doesn't provide enough detail to make a buy/sell decision. It's a data point for broader due diligence.
Key Numbers
- 670002401 — CUSIP Number (identifies Novavax Inc. common stock)
- 04-2456637 — IRS Identification No. (identifies State Street Corporation)
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Novavax Inc. (company) — the subject company whose common stock is being reported
- 0000093751-24-000204 (dollar_amount) — accession number for the filing
- December 31, 2023 (date) — the date of the event requiring the filing
Forward-Looking Statements
- State Street Corporation will maintain a significant stake in Novavax Inc. throughout 2024. (State Street Corporation) — medium confidence, target: 2024-12-31
FAQ
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, which is filed by institutional investors to report beneficial ownership of 5% or more of a company's stock, typically for passive investment purposes. The 'A' indicates it's an amendment to a previously filed statement.
Who filed this specific SC 13G/A?
This SC 13G/A was filed by State Street Corporation, as indicated by 'NAME OF REPORTING PERSON: STATE STREET CORPORATION' on page 2 of 7.
Which company's stock is the subject of this filing?
The subject company is NOVAVAX INC, as stated under 'NAME OF ISSUER' on page 1 of 7.
What was the date of the event that triggered this filing?
The date of the event which requires filing of this statement was 12/31/2023, as specified on page 1 of 7.
Under which SEC rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1 (B), as indicated by the 'X' next to 'RULE 13D-1 (B)' on page 1 of 7.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding NOVAVAX INC (NVAX).